Table 2.
Initial Medication Given: | All Primary Headache (N = 574) n (% of total) |
Headache NOS (N = 420) n (% of total) |
Migraine (N = 138) n (% of total) |
---|---|---|---|
Opiates: | 131 (22.8) | 108 (25.7) | 19 (13.8) |
•Morphine | 73 (12.7) | 63 (15.0) | 8 (5.8) |
•Dilaudid | 57 (9.9) | 44 (10.5) | 11 (8.0) |
•Fentanyl | 1 (0.2) | 1 (0.2) | 0 (0) |
Non-Opiate First-Line Recommended:1 | 303 (52.6) | 216 (51.4) | 79 (57.2) |
•Metochlopramide | 142 (24.7) | 107 (25.5) | 32 (23.2) |
•NSAIDs (Keterolac) | 97 (16.9) | 60 (14.3) | 35 (25.4) |
•Proochloperazine | 69 (12.0) | 52 (12.4) | 15 (10.9) |
•Triptans or DHE | 11 (1.9) | 4 (1.0) | 6 (4.4) |
•Acetaminophen | 1 (0.2) | 1 (0.2) | 0 (0) |
Other Non-Opiate Medications:2 | 140 (24.4) | 99 (23.6) | 40 (29.0) |
Does not include Opiate combinations. There was no use of Chlorpromazine or IV Aspirin in our cohort.
Does not include Opiate combinations. Other medications given without concurrent parenteral headache medications included (in frequency order): Other Anti-emetics (Ondansetron and Promethazine), Benzodiazepines, and Antihistamines.